Clinuvel Pharmaceuticals Limited (FRA:UR9)

Clinuvel Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Clinuvel Pharmaceuticals had annual revenue of 95.02M AUD with 7.76% growth. Clinuvel Pharmaceuticals had revenue of 59.37M in the half year ending June 30, 2025, with 21.27% growth.

• Revenue: 95.02M AUD
• Revenue Growth: +7.76%
• P/S Ratio: 6.34
• Revenue / Employee: 5.94M AUD
• Employees: 16
• Market Cap: 336.09M EUR

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	95.02M	6.84M	7.76%
Jun 30, 2024	88.18M	9.86M	12.59%
Jun 30, 2023	78.32M	12.60M	19.17%
Jun 30, 2022	65.72M	17.40M	36.02%
Jun 30, 2021	48.32M	15.75M	48.37%